GSA Capital Partners’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,747
| Closed | -$286K | – | 1944 |
|
|
2021
Q3 | $286K | Buy |
+16,747
| New | +$286K | 0.03% | 1056 |
|
|
2020
Q2 | – | Sell |
-5,114
| Closed | -$205K | – | 1260 |
|
|
2020
Q1 | $205K | Sell |
5,114
-12,624
| -71% | -$506K | 0.05% | 745 |
|
|
2019
Q4 | $702K | Buy |
+17,738
| New | +$702K | 0.08% | 424 |
|
|
2019
Q3 | – | Sell |
-60,622
| Closed | -$564K | – | 1816 |
|
|
2019
Q2 | $564K | Sell |
60,622
-30,778
| -34% | -$286K | 0.06% | 591 |
|
|
2019
Q1 | $1.27M | Sell |
91,400
-16,400
| -15% | -$228K | 0.13% | 182 |
|
|
2018
Q4 | $1.18M | Sell |
107,800
-57,000
| -35% | -$622K | 0.14% | 158 |
|
|
2018
Q3 | $2.08M | Buy |
164,800
+102,100
| +163% | +$1.29M | 0.12% | 225 |
|
|
2018
Q2 | $826K | Buy |
+62,700
| New | +$826K | 0.04% | 864 |
|